Johnson & Johnson uncooperative in House investigation
Johnson & Johnson has been seen as uncooperative in the federal investigation that has been undertaken into the company. The manufacturer and McNeil Consumer Healthcare, one of its units are under scrutiny for a pattern of violations in both manufacturing and quality control practices that Congress believes led to a number of product recalls including the recent Children's Tylenol and other over-the-counter children's medications.
The Food and Drug Administration is considering several actions against McNeil including criminal penalties. The House Committee on Oversight and Government Reform has opened investigation against the manufacturer. The House says that Johnson & Johnson has been delaying the investigation and providing misinformation. If these actions continue, Congress may take more aggressive action against the company.
The manufacturer has denied these accusations. McNeil says they have been cooperative with federal investigators, providing more than 20,000 pages of documents. The FDA also says that Johnson & Johnson has been misleading, saying that it told the agency the recent product recall including 136 million bottles of medicine while telling its own staff at the company that the recall only included 6 million.
The federal investigation was opened in May after McNeil voluntarily recalled the children's medications. The House is also looking into a phantom recall conducted by the manufacturer last year. Reportedly, McNeil hired private contractors to remove defective bottles of Motrin from stores without informing consumers.